ZAc 298.0
(7.58%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -24.05 Million | -109.27 Million | 60.94 Million | 75.53 Million | 51.81 Million | 27.37 Million |
Net Income | 77.22 Million | -24.77 Million | -24.77 Million | -39.45 Million | -138.41 Million | -51.55 Million |
Depreciation & Amortization | 1.3 Million | 1.13 Million | 1.13 Million | 109.06 Million | 101.83 Million | 67.74 Million |
Deferred income taxes | - | -146.54 Million | 23.67 Million | -71.04 Million | -8.13 Million | -75.74 Million |
Stock-based compensation | - | 374 Thousand | 374 Thousand | 748 Thousand | 2.43 Million | 489 Thousand |
Change in working capital | 16.63 Million | 53.17 Million | 53.17 Million | 20.32 Million | 33.85 Million | 33.59 Million |
Other non-cash items | -18.16 Million | 7.36 Million | 7.36 Million | 55.89 Million | 60.24 Million | 52.84 Million |
Investing Cash Flow | 205.44 Million | 149.97 Million | 582.65 Million | 53.76 Million | 287.51 Million | 33.7 Million |
Investments in PPE | -5.07 Million | -728 Thousand | -50.23 Million | -50.23 Million | -92.05 Million | -103.14 Million |
Acquisitions | 14.18 Million | 929 Thousand | 477.39 Million | -1.23 Million | -1.23 Million | 4.01 Million |
Investment purchases | - | -929 Thousand | -477.39 Million | -163.43 Million | 110.21 Million | -7.16 Million |
Sales/Maturities of investments | 20.99 Million | 929 Thousand | 477.39 Million | 260.35 Million | 260.35 Million | -4.01 Million |
Other Investing Activities | 67.09 Million | 149.76 Million | 155.49 Million | 8.31 Million | 10.22 Million | 144.02 Million |
Financing Cash Flow | -104.41 Million | -145.87 Million | -583.91 Million | -125.35 Million | -390.84 Million | -99.31 Million |
Debt repayment | -50 Million | -107.5 Million | -107.5 Million | -10.99 Million | -7.5 Million | -7.36 Million |
Dividends payments | -42.74 Million | -63.73 Million | -369.91 Million | -276 Thousand | -276 Thousand | -11 Thousand |
Common Stock Repurchased | -60.55 Million | -50 Million | -184.98 Million | -16 Million | -228.33 Million | -32 Million |
Common Stock Issuance | - | 99.69 Million | 208.52 Million | 6.06 Million | 6.06 Million | 39.36 Million |
Other Financing Activities | -373 Thousand | -36.69 Million | -130.03 Million | -104.14 Million | -160.8 Million | -99.29 Million |
Accounts receivables | 5.18 Million | -1.74 Million | 38.04 Million | 5.71 Million | -15.78 Million | -7.48 Million |
Accounts payables | 11.45 Million | -5.69 Million | 15.13 Million | 4.23 Million | 41.88 Million | 31.3 Million |
Inventory | - | 5.69 Million | 10.37 Million | 10.37 Million | 7.75 Million | 9.77 Million |
Other working capital | 11.45 Million | 54.91 Million | -10.37 Million | - | - | - |
Cash at beginning of period | 81.73 Million | 186.91 Million | 127.23 Million | 20.94 Million | 72.45 Million | 110.68 Million |
Cash at end of period | 158.7 Million | 81.73 Million | 186.91 Million | 127.23 Million | 20.94 Million | 72.45 Million |
Capital Expenditure | -5.07 Million | -728 Thousand | -50.23 Million | -50.23 Million | -92.05 Million | -103.14 Million |
Effect of forex changes on cash | - | - | - | 102.33 Million | - | - |
Net cash flow / Change in cash | 76.97 Million | -105.17 Million | 59.68 Million | 106.28 Million | -51.51 Million | -38.22 Million |
Free Cash Flow | -29.13 Million | -109.99 Million | 10.7 Million | 25.3 Million | -40.23 Million | -75.77 Million |
Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 11.37 Million | 11.37 Million | 25.44 Million | 25.44 Million | -24.77 Million | - |
Depreciation & Amortization | 653.5 Thousand | 653.5 Thousand | - | - | 1.13 Million | - |
Deferred income taxes | - | - | - | - | -146.54 Million | - |
Stock-based compensation | - | - | - | - | 374 Thousand | - |
Change in working capital | 2.59 Million | 2.59 Million | - | - | 53.17 Million | - |
Other non-cash items | -19.58 Million | -19.58 Million | -32.51 Million | -32.51 Million | 7.36 Million | - |
Investing Cash Flow | 39.2 Million | 39.2 Million | 63.52 Million | 63.52 Million | 149.97 Million | - |
Investments in PPE | 159 Thousand | 159 Thousand | -2.69 Million | -2.69 Million | -728 Thousand | - |
Acquisitions | - | - | - | - | 929 Thousand | - |
Investment purchases | - | - | - | - | -929 Thousand | - |
Sales/Maturities of investments | - | - | 14.18 Million | - | 929 Thousand | - |
Other Investing Activities | 39.04 Million | 39.04 Million | 66.22 Million | 66.22 Million | 149.76 Million | - |
Financing Cash Flow | -5.15 Million | -5.15 Million | -47.05 Million | -47.05 Million | -145.87 Million | - |
Debt repayment | - | - | -50 Million | - | -107.5 Million | - |
Dividends payments | -624 Thousand | - | -21.68 Million | -21.68 Million | -63.73 Million | - |
Common Stock Repurchased | -5.27 Million | -5.27 Million | - | - | -50 Million | - |
Common Stock Issuance | - | - | - | - | 99.69 Million | - |
Other Financing Activities | -498 Thousand | 126 Thousand | -25.37 Million | -25.37 Million | -36.69 Million | - |
Accounts receivables | 2.59 Million | 2.59 Million | - | - | -1.74 Million | - |
Accounts payables | - | - | - | - | -5.69 Million | - |
Inventory | - | - | - | - | 5.69 Million | - |
Other working capital | - | - | - | - | 54.91 Million | - |
Cash at beginning of period | - | - | 124.76 Million | - | 186.91 Million | 124.76 Million |
Cash at end of period | 29.08 Million | 29.08 Million | 100.52 Million | 9.39 Million | 81.73 Million | 124.76 Million |
Capital Expenditure | 159 Thousand | 159 Thousand | -2.69 Million | -2.69 Million | -728 Thousand | - |
Effect of forex changes on cash | - | - | -43.03 Million | - | - | - |
Net cash flow / Change in cash | 29.08 Million | 29.08 Million | -24.23 Million | 9.39 Million | -105.17 Million | - |
Free Cash Flow | -4.8 Million | -4.8 Million | -9.76 Million | -9.76 Million | -109.99 Million | - |
HABA
688609
BIOYF
6857
HMSO
GTN